Tag #Cancer Research

Showing 25 to 36 of 69 results

kathimerini.gr

🌐 75% Global Worthiness

May 25, 16:11

Evolving Understanding and Treatment of Prostate Cancer

Professor Christoforos Logothetis, a leading prostate cancer expert, discusses the evolving understanding and treatment of the disease, emphasizing the shift from immediate surgery for all diagnoses to personalized approaches based on risk assessment and advanced technologies, as highlighted by Pres...

Evolving Understanding and Treatment of Prostate Cancer

Professor Christoforos Logothetis, a leading prostate cancer expert, discusses the evolving understanding and treatment of the disease, emphasizing the shift from immediate surgery for all diagnoses to personalized approaches based on risk assessment and advanced technologies, as highlighted by Pres...

Progress

28% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How has the understanding and treatment of prostate cancer changed in recent years, considering its impact on men of all ages?

Professor Christoforos Logothetis, a renowned oncologist, highlights the evolving understanding and treatment of prostate cancer. Once considered a disease primarily affecting the elderly, prostate cancer is now recognized as impacting men of all ages, driven by advancements in detection technology and deeper biological understanding. This shift has led to the development of risk assessment methods and active surveillance strategies, replacing the previous approach of immediate surgery for all diagnoses.

smh.com.au

🌐 85% Global Worthiness

May 20, 13:15

Biden Announces Aggressive Prostate Cancer Diagnosis

Former US President Joe Biden announced he has aggressive prostate cancer that has spread to his bones; this announcement follows recent criticism of his health and comes after his son Beau died of brain cancer, prompting his work on the Cancer Moonshot program.

Biden Announces Aggressive Prostate Cancer Diagnosis

Former US President Joe Biden announced he has aggressive prostate cancer that has spread to his bones; this announcement follows recent criticism of his health and comes after his son Beau died of brain cancer, prompting his work on the Cancer Moonshot program.

Progress

60% Bias Score

ShareSaveArticle

12345678

Previous 1 of 8 Next

How does Biden's personal experience with cancer, particularly his son Beau's death, contextualize his current situation and its public reception?

Biden's cancer diagnosis highlights the deeply personal nature of health struggles, even for individuals who have dedicated their lives to combating disease. His family history, including his son Beau's death from brain cancer, adds further weight to this revelation. The announcement follows recent speculation regarding his physical and mental fitness for office.

cnnpressroom.blogs.cnn.com

🌐 85% Global Worthiness

May 14, 22:10

Documentary to Explore Rise of Early-Onset Cancer

CNN Films announced a documentary, "In the Prime of Life," exploring the 79% global increase in cancer among 18-49 year olds between 1990-2019, premiering in 2026, featuring Memorial Sloan Kettering Cancer Center patients and staff.

Documentary to Explore Rise of Early-Onset Cancer

CNN Films announced a documentary, "In the Prime of Life," exploring the 79% global increase in cancer among 18-49 year olds between 1990-2019, premiering in 2026, featuring Memorial Sloan Kettering Cancer Center patients and staff.

Progress

16% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential long-term implications of this documentary for cancer research, treatment, and public perception of early-onset cancer?

This film's impact extends beyond awareness; it could potentially spur further research funding, improved treatment protocols, and a broader societal conversation about cancer risk factors in younger adults. The exclusive access granted by MSK suggests a significant commitment to addressing this critical issue.

dailymail.co.uk

🌐 85% Global Worthiness

May 9, 10:14

Top Cancer Researcher Awaits Critical MRI Results Amidst Stage Four Brain Cancer Return

Professor Richard Scolyer, a leading cancer researcher and 2024 Australian of the Year, awaits crucial MRI results following the return of his stage four brain cancer, highlighting the unpredictable nature of glioblastoma and the need for improved treatments.

Top Cancer Researcher Awaits Critical MRI Results Amidst Stage Four Brain Cancer Return

Professor Richard Scolyer, a leading cancer researcher and 2024 Australian of the Year, awaits crucial MRI results following the return of his stage four brain cancer, highlighting the unpredictable nature of glioblastoma and the need for improved treatments.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of Professor Scolyer's upcoming MRI results for his treatment plan and life expectancy?

Professor Richard Scolyer, the 2024 Australian of the Year, faces a grim prognosis after his stage four brain cancer returned. Despite experimental treatments extending his life for nearly two years, recent scans reveal a concerning progression. He awaits MRI results to determine his next course of treatment, acknowledging the uncertainty of his remaining time.

theguardian.com

🌐 85% Global Worthiness

Apr 21, 19:14

Anti-Immigration Rhetoric Deteriorates UK's Cancer Research Capabilities

A leaked report reveals that anti-immigration rhetoric and high visa costs are deterring top cancer specialists from working in the UK, harming research, delaying treatments, and impacting patients, particularly children, with the costs to institutions like the Francis Crick Institute exceeding £500...

Anti-Immigration Rhetoric Deteriorates UK's Cancer Research Capabilities

A leaked report reveals that anti-immigration rhetoric and high visa costs are deterring top cancer specialists from working in the UK, harming research, delaying treatments, and impacting patients, particularly children, with the costs to institutions like the Francis Crick Institute exceeding £500...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the financial implications of the UK's current visa system for cancer research institutions, and how do these costs compare internationally?

The report, studied by the Cabinet Office and the Department for Science, Innovation and Technology, directly links politicians' messaging on immigration to the UK's diminished ability to attract and retain global talent in cancer research. This is causing delays in clinical trials and hindering the development of new cancer treatments, particularly impacting children with recurring or treatment-resistant cancers. The situation is further complicated by increased visa costs, making the UK less competitive compared to other countries.

theglobeandmail.com

🌐 85% Global Worthiness

Apr 10, 16:12

Terry Fox Foundation Launches US$25-Million Venture Capital Fund for Cancer Therapies

The Terry Fox Foundation is launching a US$25-million venture capital fund, partnering with Lumira Ventures to invest in Canadian startups developing cancer therapies, aiming to bridge the gap in domestic funding and accelerate the development of new treatments.

Terry Fox Foundation Launches US$25-Million Venture Capital Fund for Cancer Therapies

The Terry Fox Foundation is launching a US$25-million venture capital fund, partnering with Lumira Ventures to invest in Canadian startups developing cancer therapies, aiming to bridge the gap in domestic funding and accelerate the development of new treatments.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the main impact of the Terry Fox Foundation's new venture capital fund on the Canadian cancer research ecosystem?

The Terry Fox Foundation, known for its cancer research funding, is launching a US$25-million venture capital fund in partnership with Lumira Ventures. This fund will invest in startups developing cancer therapies, aiming to accelerate the translation of research into marketable products and improve patient outcomes. The foundation raised $39.5 million last year, allocating $25 million to research.

forbes.com

🌐 85% Global Worthiness

May 23, 07:12

Rising Colon Cancer in Young Adults Spurs Calls for Earlier Screening

36-year-old Heather Candrilli's battle with metastatic colon cancer underscores the rising incidence of the disease in young adults, prompting calls for earlier screening and increased awareness; research suggests gut bacteria may play a significant role.

Rising Colon Cancer in Young Adults Spurs Calls for Earlier Screening

36-year-old Heather Candrilli's battle with metastatic colon cancer underscores the rising incidence of the disease in young adults, prompting calls for earlier screening and increased awareness; research suggests gut bacteria may play a significant role.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the emerging research on the gut microbiome's role in colon cancer development challenge existing understandings and prevention strategies?

Candrilli's case exemplifies the rising rates of colon cancer among younger individuals, challenging traditional risk assessments. While genetic factors play a role in some cases, many, like Candrilli's, are not genetically linked, prompting research into the gut microbiome's influence on cancer development. A recent study linked the bacterial toxin colibactin to DNA damage in colon cells, suggesting a potential new avenue for understanding and preventing this disease.

lexpress.fr

🌐 90% Global Worthiness

May 17, 19:10

Curie Institute Researcher Develops Novel Cancer Therapy Targeting Iron-Dependent Metastasis

Raphaël Rodriguez, a CNRS research director at the Curie Institute, discovered that metastatic cancer cells' high iron and copper ion demand makes them vulnerable to oxidation, leading to the development of a molecule inducing 'ferropoptosis', a novel therapeutic approach published in Nature.

Curie Institute Researcher Develops Novel Cancer Therapy Targeting Iron-Dependent Metastasis

Raphaël Rodriguez, a CNRS research director at the Curie Institute, discovered that metastatic cancer cells' high iron and copper ion demand makes them vulnerable to oxidation, leading to the development of a molecule inducing 'ferropoptosis', a novel therapeutic approach published in Nature.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential long-term implications of Rodriguez's findings for cancer therapies and research methodologies?

Rodriguez's research has yielded a molecule that induces 'ferropoptosis,' a form of cell death caused by iron oxidation, offering a novel therapeutic approach. His work, recognized with awards including the CNRS Silver Medal, has implications for treating drug-resistant cancers and represents a significant advancement in cancer research.

es.euronews.com

🌐 85% Global Worthiness

May 11, 04:09

Early-Onset Cancer Rates Surge in US, Sparking Urgent Research

A US government study found a significant increase in early-onset cancers (15–49 years) between 2010 and 2019, with the most substantial rises in breast, colorectal, kidney, and uterine cancers, affecting women disproportionately (63%).

Early-Onset Cancer Rates Surge in US, Sparking Urgent Research

A US government study found a significant increase in early-onset cancers (15–49 years) between 2010 and 2019, with the most substantial rises in breast, colorectal, kidney, and uterine cancers, affecting women disproportionately (63%).

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential contributing factors to the rising rates of early-onset cancers, and how do these factors vary across different cancer types?

This study highlights a substantial increase in early-onset cancers, exceeding expected rates based on 2010 data. For example, there were approximately 4,800 extra breast cancer cases in 2019. While mortality rates remained stable for most cancers, increases were noted for colorectal, uterine, and testicular cancers, necessitating further investigation into underlying causes.

forbes.com

🌐 85% Global Worthiness

Apr 30, 19:21

Halozyme Sues Merck Over Injectable Keytruda

Merck's new injectable Keytruda faces a lawsuit from Halozyme, delaying its planned October 1 launch and highlighting upcoming patent expirations in 2028. The suit challenges Merck's use of Halozyme's hyaluronidase technology in the new injectable formulation, and Merck has said it is meritless.

Halozyme Sues Merck Over Injectable Keytruda

Merck's new injectable Keytruda faces a lawsuit from Halozyme, delaying its planned October 1 launch and highlighting upcoming patent expirations in 2028. The suit challenges Merck's use of Halozyme's hyaluronidase technology in the new injectable formulation, and Merck has said it is meritless.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of Halozyme's lawsuit on Merck's plans for its injectable Keytruda?

Merck faces a lawsuit from Halozyme over its injectable Keytruda, impacting its October 1 launch. This comes as Keytruda faces patent expirations in 2028, and the new formulation aims to boost sales and extend market life. Merck invested $1 billion in a new factory to produce the injectable version.

elpais.com

🌐 85% Global Worthiness

Apr 15, 19:17

Intracellular Galectin-1 in Pancreatic Cancer Stroma Drives Aggressiveness

An international study published in PNAS identifies Galectin-1 (Gal1) within the nuclei of pancreatic cancer stroma fibroblasts as a key driver of tumor aggressiveness, opening avenues for new therapeutic strategies targeting this protein's intracellular function to improve treatment response in thi...

Intracellular Galectin-1 in Pancreatic Cancer Stroma Drives Aggressiveness

An international study published in PNAS identifies Galectin-1 (Gal1) within the nuclei of pancreatic cancer stroma fibroblasts as a key driver of tumor aggressiveness, opening avenues for new therapeutic strategies targeting this protein's intracellular function to improve treatment response in thi...

Progress

20% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the newly discovered role of Galectin-1 (Gal1) within pancreatic cancer stroma contribute to the disease's aggressive nature and poor prognosis?

Pancreatic cancer's aggressive nature stems from its surrounding stroma, a dense, protective layer shielding tumor cells from the immune system and drugs. This stroma comprises most of the tumor mass, contributing to the low 5-year survival rate (just over 10%). A new study identifies Galectin-1 (Gal1) as a key player in this aggressive behavior.

jpost.com

🌐 85% Global Worthiness

Apr 2, 04:14

AI System scNET Improves Understanding of Cellular Drug Response

Tel Aviv University researchers developed scNET, an AI system that analyzes single-cell gene activity and interactions to reveal subtle changes in how cells respond to drug treatments, especially in cancer, as published in Nature Methods.

AI System scNET Improves Understanding of Cellular Drug Response

Tel Aviv University researchers developed scNET, an AI system that analyzes single-cell gene activity and interactions to reveal subtle changes in how cells respond to drug treatments, especially in cancer, as published in Nature Methods.

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does scNET's dual-layered approach enhance the analysis of cellular behavior compared to traditional methods?

scNET overlays gene expression data with a gene interaction map, identifying hidden activity patterns. This network-based approach allows researchers to observe how immune cells, such as T cells, increase their activity in response to treatment, enhancing the understanding of cellular responses to therapies. The improved resolution enables a more comprehensive analysis of complex biological processes, particularly in cancer treatment.

Showing 25 to 36 of 69 results